UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2013-12, Vol.19 (24), p.6891-6901

2013

Volltextzugriff (PDF)

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

British journal of cancer, 2009-10, Vol.101 (8), p.1233-1240

2009

Volltextzugriff (PDF)

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS

Neurology, 2005-03, Vol.64 (6), p.987-991

2005

Volltextzugriff (PDF)

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

British journal of cancer, 2007-02, Vol.96 (4), p.567-574

2007

Volltextzugriff (PDF)

Tasquinimod Mechanism of Action Biomarkers: Correlation with PFS and Survival in Men with Metastatic Castrate Resistant Prostate Cancer Treated in a Randomized Phase 2 Trial

Annals of oncology, 2012-09, Vol.23 (S9), p.ix303

2012

Volltextzugriff (PDF)

P049 A new preclinical rationale for first-line therapy of ulcerative colitis

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S157-S157

2020

Volltextzugriff (PDF)

Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen

The Prostate, 1999-07, Vol.40 (2), p.76-82

1999

Volltextzugriff (PDF)

Release of 17-beta-oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation

Gynecologic and obstetric investigation, 1994, Vol.38 (4), p.253-260

1994

Volltextzugriff (PDF)

Metabolism of roquinimex in mouse and rat: an in vitro/in vivo comparison

Xenobiotica, 2000-04, Vol.30 (4), p.371-380

2000

Volltextzugriff (PDF)

Phase II study of tasquinimod in chemotherapy-naive patients with metastatic castrate-resistant prostate cancer (CRPC): Safety and efficacy analysis including subgroups

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.126-126

2011

Volltextzugriff (PDF)

Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer

Annals of oncology, 1995-11, Vol.6 (9), p.948-949

1995

Volltextzugriff (PDF)

Dissolution rate-limited absorption and complete bioavailability of roquinimex in man

Biopharmaceutics & drug disposition, 1999-10, Vol.20 (7), p.347-354

1999

Volltextzugriff (PDF)

126 Long term safety and efficacy in a randomized multicenter international phase II study of tasquinimod in chemotherapy naïve patients with metastatic castrate-resistant prostate cancer

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e126-e126a

2012

Volltextzugriff (PDF)

Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1115-1127

Hudes, G.

2002

Volltextzugriff (PDF)

Immediate estrogen or estramustine phosphate therapy versus deferred endocrine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. The South Sweden Prostate Cancer Study Group

The Journal of urology, 1995-05, Vol.153 (5), p.1580-1586

1995

Volltextzugriff (PDF)

Treatment of High-grade, High-stage Prostate Cancer with Estramustine Phosphate or Diethylstilbestrol: A double-blind Study

Scandinavian journal of urology and nephrology, 1997-01, Vol.31 (2), p.167-172

1997

Volltextzugriff (PDF)

A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result

Gastroenterology (New York, N.Y. 1943), 1982-09, Vol.83 (3), p.550

1982

Volltextzugriff (PDF)

Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen

The Prostate, 1999, Vol.40 (2), p.76

1999

Volltextzugriff (PDF)

Immediate Estrogen or Estramustine Phosphate Therapy Versus Deferred Endocrine Treatment in Nonmetastatic Prostate Cancer: A Randomized Multicenter Study With 15 Years of Followup

The Journal of urology, 1995, Vol.153 (5), p.1580-1586

1995

Volltextzugriff (PDF)

Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study

Scandinavian journal of urology and nephrology. Supplement, 1980, Vol.55, p.143

1980

Volltextzugriff (PDF)

A self‐adjusting randomization plan for allocation of patients into two treatment groups

Clinical pharmacology and therapeutics, 1977-12, Vol.22 (6), p.825-830

1977

Volltextzugriff (PDF)

A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations

Gastroenterology (New York, N.Y. 1943), 1982-09, Vol.83 (3), p.541-549

1982

Volltextzugriff (PDF)

Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients

Hereditas, 1982-05, Vol.96 (2), p.279-286

1982

Volltextzugriff (PDF)

Treatment of high-grade, high-stage prostate cancer with estramustine phosphate or diethylstilbestrol. A double-blind study. The SPCG-1 Study Group. Scandinavian Prostate Cancer Group

Scandinavian journal of urology and nephrology, 1997-04, Vol.31 (2), p.167

1997

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

Tasquinimod Mechanism of Action Biomarkers: Correlation with PFS and Survival in Men with Metastatic Castrate Resistant Prostate Cancer Treated in a Randomized Phase 2 Trial

P049 A new preclinical rationale for first-line therapy of ulcerative colitis

Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen

Release of 17-beta-oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation

Metabolism of roquinimex in mouse and rat: an in vitro/in vivo comparison

Phase II study of tasquinimod in chemotherapy-naive patients with metastatic castrate-resistant prostate cancer (CRPC): Safety and efficacy analysis including subgroups

Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer

Dissolution rate-limited absorption and complete bioavailability of roquinimex in man

126 Long term safety and efficacy in a randomized multicenter international phase II study of tasquinimod in chemotherapy naïve patients with metastatic castrate-resistant prostate cancer

Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate

Immediate estrogen or estramustine phosphate therapy versus deferred endocrine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. The South Sweden Prostate Cancer Study Group

Treatment of High-grade, High-stage Prostate Cancer with Estramustine Phosphate or Diethylstilbestrol: A double-blind Study

A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result

Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen

Immediate Estrogen or Estramustine Phosphate Therapy Versus Deferred Endocrine Treatment in Nonmetastatic Prostate Cancer: A Randomized Multicenter Study With 15 Years of Followup

Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study

A self‐adjusting randomization plan for allocation of patients into two treatment groups

A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations

Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients

Treatment of high-grade, high-stage prostate cancer with estramustine phosphate or diethylstilbestrol. A double-blind study. The SPCG-1 Study Group. Scandinavian Prostate Cancer Group

Suchergebnisse filtern